Structure Info
- Chemspace ID
- CSCS00025778876 (Synthesis)
- CAS
- 1528564-50-2
- MFCD
- MFCD30535665
- IUPAC Name
- 1-{spiro[2.3]hexan-5-yl}methanamine hydrochloride
- Mol formula
- C7H14ClN
- Mol weight
- 148 Da
- Catalog Number(s)
- AT30113, AW39596, ArZ-UP223460, BB4LS-EN300-332218, BBV-108663640, BD01403611, BVV-820826687, CS-0254812, CSC025778876, DLC56450, EN300-332218, F668149, SY220209, Y3196505, ZX-NM201307, ZXC302993
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 0.72
- Heavy atoms count
- 9
- Rotatable bond count
- 1
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 1
- Polar surface area (Å)
- 26
- Hydrogen bond acceptors count
- 1
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSCS00025778876
Items Overall 11 items from 5 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BLD Pharmatech Co., Limited | 30 days | United States To: | 98 | 250 mg | 998 | |
| BLD Pharmatech Co., Limited | 30 days | United States To: | 98 | 1 g | 2,140 | |
Description: Name:Spiro[2.3]hexan-5-ylmethanamine hydrochloride; CAS: 1528564-50-2 | ||||||
| BLD Pharmatech GmbH | 30 days | Germany To: | 98 | 250 mg | 998 | |
| BLD Pharmatech GmbH | 30 days | Germany To: | 98 | 1 g | 2,140 | |
Description: Name:Spiro[2.3]hexan-5-ylmethanamine hydrochloride; CAS: 1528564-50-2 | ||||||
| eNovation CN | 40 days | China To: | 95 | 50 mg | 483 | |
| eNovation CN | 40 days | China To: | 95 | 100 mg | 696 | |
| eNovation CN | 40 days | China To: | 95 | 250 mg | 989 | |
| eNovation CN | 40 days | China To: | 95 | 500 mg | 1,558 | |
| eNovation CN | 40 days | China To: | 95 | 1 g | 1,989 | |
Description: {spiro[2.3]hexan-5-yl}methanamine hydrochloride; CAS: 1528564-50-2 | ||||||
| Astatech Inc | TBD | United States To: | 95 | 1 g | POA | |
| Zerenex Molecular Ltd | TBD | United Kingdom To: | 95 | 1 g | POA | |
Description: CAS: 1528564-50-2 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire